SERGIO SANCHEZ: Open Payments
NPI 1912948647 · GREER, SC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$5,559 in 32 payments from 9 companies in 2025. Trend: 2023 $11,817 · 2024 $8,650 · 2025 $5,559
Speaker / faculty: $4,620Food & beverage: $939
| Company | Payments | Amount |
|---|---|---|
| Teva Pharmaceuticals USA, Inc. | 9 | $4,805 |
| E.R. Squibb & Sons, L.L.C. | 10 | $322 |
| Alkermes, Inc. | 4 | $194 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 3 | $138 |
| ABBVIE INC. | 2 | $34 |
| Axsome Therapeutics, Inc. | 1 | $20 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $18 |
| Janssen Pharmaceuticals, Inc | 1 | $14 |
| Otsuka America Pharmaceutical, Inc. | 1 | $14 |
Products named: UZEDY, COBENFY, ARISTADA, CAPLYTA, AUSTEDO XR, VRAYLAR, Auvelity, TRINTELLIX.
Industry payments across SC — which companies pay providers there.
